All News

Found 265 articles

• Daxor Corporation Revises 2017 Dividend

  12/29/2017

  This dividend will be paid on Friday, January 12, 2018 to Daxor shareholders of record on Monday January 8, 2018.

• Daxor Corporation Announces 2017 Dividend

  12/21/2017

  Daxor Corporation announced the payment of a dividend for 2017.

• Daxor Corporation Announces Share Buyback Program

  11/1/2017

  The Board of Directors of Daxor has voted to re-authorize the company’s share buyback for an amount of up to 300,000 shares for the next 12 months.

• Daxor Corporation Forwarding Plans To Expand Impact At HFSA 2017 And Beyond

  9/19/2017

• Daxor Corporation Holds Annual Meeting, Provides Business Growth Update And Strategic Plan

  6/30/2017

• Daxor Corporation Announces Hiring Of Chief Financial Officer

  6/2/2017

• Daxor Corporation Announces Delay In Filing Of Form N-CSR For December 31, 2016, And The Uniformed Services University Of Health Sciences Has Been Awarded A Grant To Study Hemodilution Utilizing Daxor's BVA-100 Device

  4/12/2017

• Daxor Corporation Announces Death Of Founder, Chief Medical Officer, And Developer Of Blood Volume Analysis And Inventor Of The Daxor BVA-100 Device, Dr. Joseph Feldschuh

  2/2/2017

• Daxor Corporation Release: SCCM17 Randomized Controlled Trial Analysis: Individualized Volume Management Guided By Direct Blood Volume Analysis (BVA) Sharply Lowers Early ICU Mortality Vs Pulmonary Artery Catheter Alone

  1/30/2017

• Daxor Corporation Announces Dividend, Patent Approval, Title Change

  11/21/2016

• Daxor Corporation Release: Two New Studies From Mayo Clinic And Lankenau Medical Center Presented At Heart Failure Society Of America 2016 Highlight Unique Ability Of BVA To Identify High Risk At Discharge In Hospitalized Heart Failure Patients

  9/29/2016

• Daxor Corporation Announces Filing Of Form N-CSR for June 30, 2016

  9/15/2016

• In Heart Failure, One Size Does Not Fit All: New Mayo Clinic BVA Study Published In Journal Of American College of Cardiology-Heart Failure Highlights The Need For Individualized Decongestive Strategies

  7/27/2016

• Daxor Corporation Announces Hiring of Chief Financial Officer

  6/17/2016

• University of Hawaii And The Queen's Medical Center Reports On A Study On Critically Ill Patients Utilizing Blood Volume Measurement And Pulmonary Artery Catheterization

  3/10/2016

• Daxor Corporation Announces Upcoming Filing Of Form N-CSR For December 31, 2015 And Recent Developments

  3/1/2016

• Daxor Corporation Announces Return Of Dr. Joseph Feldschuh After Pancreatic Cancer Surgery

  2/17/2016

• Daxor Corporation Announces Sale Of BVA-100 Blood Volume Analyzer To Nebraska Medicine

  2/8/2016

• Daxor Corporation Announces An Increased Dividend And The Appointment Of Michael Feldschuh As President And Chief Executive Officer On A Temporary Basis

  12/11/2015

• Second Heart Failure Study From The Mayo Clinic Utilizing Daxor Corporation's BVA-100 Blood Volume Analyzer Published In Journal Of Cardiovascular Trans. Res. (2015) 8:404-410

  11/30/2015